| Recruitment status | Open public recruiting |
| Unique ID issued by UMIN | UMIN000048967 |
| Receipt No. | R000055789 |
| Scientific Title | Assessment of spontaneous inspiratory effort using inspiratory muscle echocardiography in patients with ARDS |
| Date of disclosure of the study information | 2022/09/20 |
| Last modified on | 2022/09/20 (Ver. 1) |
| Basic information | ||
| Public title | Assessment of spontaneous inspiratory effort using inspiratory muscle echocardiography in patients with ARDS | |
| Acronym | MUSCLE echo-ARDS study | |
| Scientific Title | Assessment of spontaneous inspiratory effort using inspiratory muscle echocardiography in patients with ARDS | |
| Scientific Title:Acronym | MUSCLE echo-ARDS study | |
| Region |
|
|
| Condition | ||
| Condition | Acute respiratory distress syndrome (ARDS) | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | This study investigate whether spontaneous inspiratory effort can be accurately assessed by diaphragmatic and intercostal muscle echocardiography in patients with ARDS |
| Basic objectives2 | Others |
| Basic objectives -Others | If we can confirm that noninvasive echocardiography can be used to evaluate spontaneous inspiratory effort without an intraesophageal pressure balloon |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | To determine whether the thickening fraction of diaphragmatic and intercostal muscle echoes can predict strong spontaneous breathing (delta Pes>10 cmH2O) |
| Key secondary outcomes | |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | - Patients diagnosed with ARDS and undergoing invasive ventilatory management with PaO2/FiO2 < 150 mmHg
- Patients who require an esophageal pressure catheter for monitoring |
|||
| Key exclusion criteria | - There is a contraindication to esophageal pressure catheter insertion (varices, postoperative upper gastrointestinal tract, or other physician's judgment)
- History of neuromuscular disease (history of stroke not affecting respiratory muscles is not an exclusion) - Intercostal muscle echocardiography is affected after an invasive intervention on the thorax, such as after cardiovascular surgery or thoracic surgery - If thoracic deformity is present - If the patient has chronic respiratory failure using home oxygen therapy or non-invasive ventilation |
|||
| Target sample size | 24 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Nerima Hikarigaoka Hospital | ||||||
| Division name | Department of Critical Care Medicine | ||||||
| Zip code | 179-0072 | ||||||
| Address | 2-11-1, Hikarigaoka, Nerima-ku, Tokyo, Japan | ||||||
| TEL | 0339793611 | ||||||
| rdcyc910@yahoo.co.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Nerima Hikarigaoka Hospital | ||||||
| Division name | Department of Critical Care Medicine | ||||||
| Zip code | 179-0072 | ||||||
| Address | 2-11-1, Hikarigaoka, Nerima-ku, Tokyo, Japan | ||||||
| TEL | 0339793611 | ||||||
| Homepage URL | |||||||
| rdcyc910@yahoo.co.jp | |||||||
| Sponsor | |
| Institute | Nerima Hikarigaoka Hospital |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Not applicable |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | Department of Emergency and Critical Care Medicine, St. Marianna University |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Ethics committee, Nerima Hikarigaoka Hospital |
| Address | 2-11-1, Hikarigaoka, Nerima-ku, Tokyo, Japan |
| Tel | 0339793611 |
| hidetoshiy@jadecom.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Open public recruiting | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | - If the patient is on assisted ventilation (AC-PC or PSV) with spontaneous breathing, measure daily (up to day 7).
- Confirm that the patient is breathing steadily and record ventilator settings and arterial blood gas findings at that time. - Diaphragmatic echo is measured in the ninth or tenth intercostal space between the mid-axilla or anterior axis - Intercostal muscle echo is measured at the right margin of the sternum in the second intercostal space. - A high-frequency linear probe is used and the probing site is marked for consistency of daily measurements. - End-expiratory and end-inspiratory diameters are measured and recorded for three stable breaths. - TFic and TFdi are calculated from end expiratory and end inspiratory diameters and averaged over 3 stable breaths - Delta Pes and delta PL-dyn are measured as monitoring by esophageal pressure balloon. (When Hamilton G5/C6 is used, PTPes is also recorded in the same way.) - If the ventilator is capable of measurement, P0.1 and delta Pocc are measured and the average of 3 stable breaths is calculated. - Determine the need for continuous daily use of muscle relaxation; if there are strong spontaneous breaths and the clinician determines that muscle relaxation is needed, this should be clearly indicated. - Measure Crs and Rrs after subsequent use of muscle relaxation |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000055789 |